Search Results - "Datsenko, Y"

P721 INTERFERON-STIMULATED GENE EXPRESSION IS ASSOCIATED WITH TREATMENT RESPONSE TO FALDAPREVIR PLUS PEGYLATED INTERFERON a-2a AND RIBAVIRIN IN PATIENTS WITH CHRONIC HCV GENOTYPE-1 INFECTION by Datsenko, Y, Baum, P, Schirmbeck, R, Stern, J.O, Sha, N, Steinmann, G.G

Get full text

P738 NO CLINICALLY RELEVANT DRUG–DRUG INTERACTIONS BETWEEN FALDAPREVIR AND PEGYLATED INTERFERON a-2a PLUS RIBAVIRIN IN HCV-INFECTED PATIENTS: PHARMACOKINETIC ANALYSES FROM TWO PHASE II STUDIES by Bourlière, M, Sulkowski, M, Manns, M.P, Asselah, T, Ferenci, P, Pol, S, Berg, T, Lalezari, J, Quinson, A.-M, Datsenko, Y, Scherer, J, Yong, C.-L, Huang, F

Get full text

P724 VIROLOGICAL RESPONSE IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV GENOTYPE-1 INFECTION RECEIVING FALDAPREVIR PLUS PEGYLATED INTERFERON a-2a AND RIBAVIRIN IS UNAFFECTED BY RIBAVIRIN DOSE REDUCTION by Asselah, T, Jensen, D.M, Foster, G.R, Sulkowski, M.S, Ouzan, D, Morano, L, Buynak, R, Agarwal, K, Hassanein, T, Forton, D, Cho, M, Genné, D, Kaita, K, Maieron, A, Preotescu, L, Sarrazin, C, Zehnter, E, Streinu-Cercel, A, Stern, J.O, Datsenko, Y, Drulak, M, Voss, F, Quinson, A.-M, Ferenci, P

Get full text

P1118 NO EFFECT OF FALDAPREVIR ON RENAL FUNCTION IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV GENOTYPE-1 INFECTION: POOLED DATA FROM TWO PHASE III TRIALS by Zeuzem, S, Jensen, D.M, Carvalho, A, Diago, M, Feinman, S.V, Kowdley, K.V, Kao, J.-H, Maevskaya, M, Negro, F, Mantry, P, Tanaka, Y, Forton, D, Genné, D, Paik, S.W, Zehnter, E, Kuboki, M, Lee, W.M, Peng, C.-Y, Yatsuhashi, H, Stern, J.O, Datsenko, Y, Drulak, M, Voss, F, Böcher, W, Ferenci, P

Get full text

1185 CHARACTERIZATION OF HCV NS3 VARIANTS THAT EMERGED DURING VIROLOGIC BREAKTHROUGH AND RELAPSE FROM BI 201335 PHASE II SILEN-C2 STUDY IN PEGIFN/RBV TREATMENT-EXPERIENCED PATIENTS by Kukolj, G, Bethell, R, Cartier, M, Cote-Martin, A, Lagace, L, Marquis, M, Triki, I, Sulkowski, M, Asselah, T, Lalezari, J, Ferenci, P, Bocher, W.O, Datsenko, Y, Nehmiz, G, Scherer, J, Steinmann, G, Stern, J.O

Get full text

60 SILEN-C1: SUSTAINED VIROLOGIC RESPONSE (SVR) AND SAFETY OF BI201335 COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN (P/R) IN TREATMENT-NAIVE PATIENTS WITH CHRONIC GENOTYPE 1 HCV INFECTION by Sulkowski, M.S, Ceasu, E, Asselah, T, Caruntu, F.A, Lalezari, J, Ferenci, P, Streinu-Cercel, A, Fainboim, H, Tanno, H, Preotescu, L, Leggett, B, Bessone, F, Mauss, S, Stern, J.O, Häfner, C, Datsenko, Y, Nehmiz, G, Böcher, W, Steinmann, G

Get full text

66 SILEN-C2: SUSTAINED VIROLOGIC RESPONSE (SVR) AND SAFETY OF BI201335 COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN (P/R) IN CHRONIC HCV GENOTYPE-1 PATIENTS WITH NON-RESPONSE TO P/R by Sulkowski, M.S, Bourliere, M, Bronowicki, J.-P, Streinu-Cercel, A, Preotescu, L, Asselah, T, Pawlotsky, J.-M, Shafran, S, Pol, S, Caruntu, F.A, Mauss, S, Larrey, D, Häfner, C, Datsenko, Y, Stern, J.O, Kubiak, R, Böcher, W, Steinmann, G

Get full text

1190 SILEN-C2: EARLY ANTIVIRAL ACTIVITY AND SAFETY OF BI 201335 COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN (PEGIFN/RBV) IN CHRONIC HCV GENOTYPE-1 PATIENTS WITH NON-RESPONSE TO PEGIFN/RBV by Sulkowski, M, Bourliere, M, Bronowicki, J.-P, Streinu-Cercel, A, Preotescu, L, Asselah, T, Pawlotsky, J.-M, Shafran, S, Pol, S, Caruntu, F.A, Mauss, S, Larrey, D, Häfner, C, Datsenko, Y, Stern, J, Kubiak, R, Steinmann, G

Get full text

Mathematical Model of Water Dynamics and Pollutant Spreading in the Ivan'kovo Reservoir by Datsenko, Y S, Ivanenko, SA, Koryavov, P P, Edel'shtein, K K

“…The principles of a mathematical model for describing the dynamics of water in a flow-through unstratified reservoir are presented. The numerical method and…”
Get full text

Heart valve prosthesis after mitral commissurotomy by Amosov, N M, Datsenko, N Ia

Get more information